Related Experiment Video
Updated: Jan 9, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Exploring the carcinoid crisis: insights from a cancer-specific centre
Maribel Del Olmo-García1,2, Grace Kong3,4, HuiLi Wong4,5
1Department of Endocrinology and Nutrition, University and Polytechnic Hospital La Fe, Valencia, Spain.
Carcinoid crisis (CC) occurred in 43% of procedures in patients with carcinoid syndrome (CS). Pre-procedure biomarkers and intraoperative hypotension are key to managing CC risk and outcomes.
Area of Science:
- Endocrinology
- Oncology
- Cardiology
Background:
- Carcinoid syndrome (CS) patients undergoing procedures are at risk of carcinoid crisis (CC).
- Understanding CC prevalence and risk factors is crucial for patient management.
Purpose of the Study:
- To determine the incidence, pre-procedure biomarkers, and management strategies for carcinoid crisis (CC) in a specialized cancer hospital.
- To identify factors associated with CC and its impact on patient outcomes.
Main Methods:
- Retrospective observational study of 48 patients with CS undergoing 71 procedures over 5 years.
- CC incidence assessed using strict (<80 mmHg SBP for >10 min) and broad criteria (severe hemodynamic instability).
- Electronic hemodynamic data and patient records were analyzed.
Main Results:
- CC occurred in 43% of procedures by broad criteria and 20% by strict criteria; no CC during systemic therapies.
- Strictly defined CC was associated with higher chromogranin A, 5-HIAA, BNP, longer hospital stay, and more postoperative complications.
- Lower intraoperative mean arterial pressure (MAP) correlated with worse postoperative outcomes and longer hospital stay.
Conclusions:
- Pre-operative biomarker assessment is vital for identifying CS patients at risk of CC.
- Intraoperative hypotension is a significant predictor of adverse postoperative outcomes and a key definition for CC in this cohort.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
Related Concept Videos
Cancer Survival Analysis
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers